Robust Supply Chain

Medicines are a critical part of medical care. Their importance becomes particularly evident when the active ingredient required for treatment is not available. That is why we are working to give as many people as possible access to high quality, affordable and safe medicines. An essential prerequisite for this is the reliable availability of active ingredients.

Multi-sourcing: a clever procurement strategy for more security

At hameln pharma, we have specialized in the licensing and distribution of our generic injectables in recent years. Our goal: the reliable supply of medicines to as many people as possible. With the help of our multi-sourcing strategy with a focus on Europe, as well as the trusting and long-term cooperation with active ingredient and finished product manufacturers, we ensure the highest possible availability of our products.

We leave nothing to chance when it comes to the production of active ingredients

One of our main focuses is the supply of opioid analgesics – drugs that should always be available. For this reason, we have some key active ingredients such as sufentanil, alfentanil and remifentanil manufactured by our sister company, hameln rds s.r.o. in Slovakia.


Business Development

We want our products to help alleviate people's suffering. That is why, in addition to licensing-in molecules to supplement our product range, we are always interested in new partnerships.


hameln pharma owns eight companies worldwide. The head office in Hameln, Germany and companies in the United Kingdom, Denmark, Norway, Sweden, the Netherlands, Hong Kong and Australia.

Pressekontakt per Mail oder Telefon


You are in safe hands with us. Our experienced team is always happy to help. Our contact page will direct you and your enquiry to the relevant contact.